【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Product Profiles
05.1 Mirapex/Sifrol/Mirapexin
05.2 Requip
05.3 Neupro/Leganto
05.4 HORIZANT/Regnite
06.Introduction
07.Disease Overview
07.1 Understanding RLS
07.1.1 Types of RLS
07.2 Etiology and Pathogenesis
07.2.1 Genetic Factors
07.2.2 Iron Deficiency
07.2.3 Other Disease Conditions/Medications
07.2.4 Neurological Disturbances
07.3 Signs and Symptoms
07.4 Diagnosis
07.4.1 Differential Diagnosis of RLS
07.5 Management
07.5.1 Pharmacological Therapy
07.5.2 Non-pharmacological Therapy
07.6 Epidemiology
07.7 Economic Burden
08.Pipeline Analysis
08.1 Key Information on Pipeline Candidates
08.1.1 Injectafer
08.1.2 Lisuride
08.1.3 Incobotulinumtoxin A
08.1.4 IPX-159
08.1.5 Safinamide
08.1.6 AZ-008
08.1.7 SER-214
09.Commercial Opportunities
10.Key Brand Analysis
11.Market Landscape
11.1 Market Overview
11.2 Market Size and Forecast
11.3 Five Forces Analysis
12.Market Segmentation by Class of Drugs
12.1 Dopaminergic Drugs
12.2 Opioids
12.3 Anticonvulsants
12.4 Sedatives and Hypnotics
12.5 Others
13.Geographical Segmentation
13.1 Global Restless Legs Syndrome Market by Geography 2014-2019
14.Buying Criteria
15.Market Growth Drivers
16.Drivers and their Impact
17.Market Challenges
18.Impact of Drivers and Challenges
19.Market Trends
20.Trends and their Impact
21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2014
21.2.1 UCB
21.2.2 GlaxoSmithKline
21.2.3 Boehringer Ingelheim
21.2.4 XenoPort
21.3 Other and Future Prominent Vendors
22.Key Vendor Analysis
22.1 Boehringer Ingelheim
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Business Segmentation by Revenue 2013
22.1.4 Business Segmentation by Revenue 2012 and 2013
22.1.5 Geographical Segmentation by Revenue 2013
22.1.6 Business Strategy
22.1.7 Recent Developments
22.1.8 SWOT Analysis
22.2 GlaxoSmithKline
22.2.1 Key facts
22.2.2 Business overview
22.2.3 Business segmentation by revenue 2014
22.2.4 Business segmentation by revenue 2013 and 2014
22.2.5 Geographical segmentation by revenue 2014
22.2.6 Business strategy
22.2.7 Recent developments
22.2.8 SWOT analysis
22.3 UCB
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Product Segmentation by Revenue 2013
22.3.4 Product Segmentation by Revenue 2012 and 2013
22.3.5 Geographical Segmentation by Revenue 2013
22.3.6 Business Strategy
22.3.7 Recent Developments
22.3.8 SWOT Analysis
22.4 XenoPort
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Strategy
22.4.4 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Types of RLS
Exhibit 3: Prevalence of Primary and Secondary RLS 2014
Exhibit 4: Types of RLS based on Onset of Disease
Exhibit 5: Etiology of RLS
Exhibit 6: Symptoms of RLS
Exhibit 7: Differential Diagnosis of RLS
Exhibit 8: Treatment Options for RLS
Exhibit 9: Prevalence of RLS Based on Gender
Exhibit 10: Pipeline Portfolio of Global Restless Legs Syndrome Market
Exhibit 11: Commercial Opportunities for Global Restless Legs Syndrome Market
Exhibit 12: Global Restless Legs Syndrome Market 2014-2019 ($ millions)
Exhibit 13: Global Restless Legs Syndrome Market by Class of Drugs
Exhibit 14: Global Restless Legs Syndrome Market by Geography 2014
Exhibit 15: Vendor Ranking 2014
Exhibit 16: Neupro: YoY Growth Rate and Revenue 2010-2014 ($ millions)
Exhibit 17: Neupro: Region-wise Revenue Comparison 2012-2014 ($ millions)
Exhibit 18: Requip: YoY Growth Rate and Revenue 2010-2014 ($ millions)
Exhibit 19: Region-wise Revenue Comparison of Requip 2012-2014 ($ millions)
Exhibit 20: HORIZANT: US Revenue 2013-2014 ($ millions)
Exhibit 21: Regnite: Revenue in Japan 2013-2014 ($ millions)
Exhibit 22: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 23: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 24: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 25: GlaxoSmithKline: Business segmentation by revenue 2014
Exhibit 26: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billion)
Exhibit 27: GlaxoSmithKline: Geographical segmentation by revenue 2014
Exhibit 28: UCB: Product Segmentation by Revenue 2013
Exhibit 29: UCB: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 30: UCB: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：むずむず脚症候群（RLS）治療薬の世界市場2015-2019■ 英文：Global Restless Legs Syndrome Market 2015-2019
■ 発行日：2015年6月10日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6054
■ 調査対象地域：グローバル
- 世界のエピネフリン自動注入装置市場動向（2012-2016）TechNavio's analysts forecast the Global Epinephrine Auto-injector market to grow at a CAGR of 13.34 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of allergies. The Global Epinephrine Auto-injector market has also been witnessing the development of chlorofluorocarbon-free epinephrine auto-injector inhalers. However, the ad …
- 産業用ファイバレーザの世界市場2016-2020About Fiber Laser A fiber laser is a different form of solid-state laser that uses a medium of fiber covering instead of a shaft. The fiber in fiber lasers uses more surface area to disperse the heat quite easily. The increasing need for compact components in a variety of industries is bringing lasers into applications. Lasers help in the miniaturization process by providing a highly focused beam …
- カロテノイドの世界市場：アスタキサンチン、ベータカロチン、カンタキサンチン、ルテイン、リコピン、ゼアキサンチンThe carotenoids market is projected to grow at a CAGR of 3.78% to reach USD 1.53 Billion by 2021. The market growth is driven by the increasing awareness about the pharmaceutical and cosmetic uses of carotenoids and the industrialization of pork, poultry, and aquaculture industry. The market is further driven by factors such as increasing end-use applications of carotenoids and rising demand for n …
- 世界の水性塗料市場予測（～2019）The report covers the global waterborne coatings market and further divides the market on the basis of resin type, application, and region. The market data for these types is given with respect to volume (thousand tons) and value ($illion). The global market value of waterborne coatings was estimated to be $52,917 million in 2012 and is projected to grow at a CAGR of about 5.92% between 2014 and 2 …
- デジタルボールトの世界市場予測（～2023年）The global digital vault market size to grow at a CAGR of 13.6% during the forecast periodThe digital vault market size is expected to grow approximately from USD 471 million in 2018 to USD 892 million by 2023, at a Compound Annual Growth Rate (CAGR) of 13.6% during the forecast period. The increasing regulations and compliances to protect sensitive data, and rising concerns for protecting data fr …
- 世界の運動用フットウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Athletic Footwear market to grow at a CAGR of 1.75 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for comfortable footwear. The Global Athletic Footwear market has also been witnessing the increasing demand for lightweight athletic shoes. However, the increasing availability of counterfe …
- 世界のメチルエチルケトン(MEK)市場2015The Global Methyl Ethyl Ketone (MEK) Industry Report 2015 is a professional and in-depth study on the current state of the Methyl Ethyl Ketone (MEK) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Methyl Ethyl Ketone (MEK) market analysis is provided for the international markets including developm …
- シャドー・バンキング・システムの世界市場2016-2020About the Shadow Banking Market A Shadow banking system is a network of financial institutions comprising non-depository banks like the structured investment vehicles, hedge funds, investment banks, and money market funds. Based on the size and scale of operations these financial intermediaries are classified as small to big insurance brokerage firms or financial institutions. The services offered …
- 世界のPOC分析装置市場：医療機器パイプライン分析2016Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at …
- 世界における医療保険取引IT市場動向及び予測（～2018）The global HIX ITmarket is valued at an estimated $1,609 million in 2013 and is expected to grow at a CAGR of 10.5% in the next five years. The global HIX IT market is mainly categorized by exchange type, phase, component, and end user. Private exchanges are expected to register the fastest growth rate among the HIX market by exchange type during the forecast period.Their favorable growth is attri …
- Freehold Royalties Ltd.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Freehold Royalties Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Freehold Royalties Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- 世界のデータセンターセキュリティ市場The latest trending markets in Information Technology (IT) are virtualized data centers and cloud services. There has been also a significant increase in the growth of mega data centers. The current market for IT is also looking at the increased global IT spending and a significant rise in the spending of enterprises for the security solutions to safeguard their data and critical IT infrastructure …
- 世界のOTC医薬品（大衆薬）市場動向（2012-2016）TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. H …
- 腰部脊柱管狭窄症治療のグローバル臨床試験動向（2014年H2）Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lumbar Spinal Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Lumbar Spinal Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lumbar Spinal Stenosis. It includes an overview of the trial numbers and …
- BP Prudhoe Bay Royalty Trust：石油・ガスの開発・生産動向及びコスト分析- Q4, 2012BP Prudhoe Bay Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2012 Summary BP Prudhoe Bay Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
